Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol vs Oral Iron for Anemia in Hemodialysis Patients
NCT00233597Phase 3Completed
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Start
- Aug 2004
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferumoxytol in anemia, sponsored by AMAG Pharmaceuticals, Inc.. Started Aug 2004; status: completed.
02
Drugs
ferumoxytol
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00233597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233597.